申请人:Dinnell Kevin
公开号:US20120136009A1
公开(公告)日:2012-05-31
This invention relates to modulation of the α7 nicotinic acetylcholine receptor (nAChR) by a compound of formula (I) or a salt thereof:
wherein R
1
is imidazolyl, pyridinyl or pyrimidinyl, any of which is optionally substituted by one group independently selected from C
1-3
alkyl and C
1-3
alkoxy.
本发明涉及利用式(I)的化合物或其盐对α7烟碱乙酰胆碱受体(nAChR)进行调制:其中R1为咪唑基、吡啶基或嘧啶基,其中任一种可选择地由一个独立选择自C1-3烷基和C1-3烷氧基的基团取代。